D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$875M |
| 4 |
Tesla
TSLA
|
+$835M |
| 5 |
Eli Lilly
LLY
|
+$643M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$939M |
| 2 |
Palantir
PLTR
|
+$668M |
| 3 |
Apple
AAPL
|
+$644M |
| 4 |
Workday
WDAY
|
+$525M |
| 5 |
Spotify
SPOT
|
+$451M |
Sector Composition
| 1 | Technology | 20.55% |
| 2 | Consumer Discretionary | 13.27% |
| 3 | Healthcare | 12.29% |
| 4 | Financials | 8.39% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INVX
2151
Innovex International, Inc.
INVX
$1.14B
| $652K | ﹤0.01% |
46,671
-95,103
| -67% | -$1.33M |
|
2152
Revolution Medicines
RVMD
$8.7B
| $649K | ﹤0.01% |
14,831
-25,178
| -63% | -$1.1M |
|
2153
Safe Bulkers
SB
$466M
| $648K | ﹤0.01% |
+181,472
| New | +$648K |
|
2154
Newmark Group
NMRK
$3.41B
| $647K | ﹤0.01% |
50,480
+31,974
| +173% | +$410K |
|
2155
Summit Therapeutics
SMMT
$14.1B
| $643K | ﹤0.01% |
36,021
-366,146
| -91% | -$6.53M |
|
2156
American States Water
AWR
$2.82B
| $642K | ﹤0.01% |
8,262
-18,076
| -69% | -$1.4M |
|
2157
Nutanix
NTNX
$21.2B
| $639K | ﹤0.01% |
10,446
-343,784
| -97% | -$21M |
|
2158
SPDR S&P Semiconductor ETF
XSD
$1.48B
| $639K | ﹤0.01% |
2,570
+300
| +13% | +$74.5K |
|
2159
Apellis Pharmaceuticals
APLS
$3.14B
| $638K | ﹤0.01% |
+20,000
| New | +$638K |
|
|
BBUC
2160
Brookfield Business Corp
BBUC
$2.37B
| $635K | ﹤0.01% |
26,175
+3,117
| +14% | +$75.6K |
|
2161
Haleon
HLN
$43.9B
| $634K | ﹤0.01% |
66,458
-339,059
| -84% | -$3.23M |
|
2162
Costamare
CMRE
$1.48B
| $633K | ﹤0.01% |
+49,247
| New | +$633K |
|
|
ARMN
2163
Aris Mining
ARMN
$1.98B
| $632K | ﹤0.01% |
180,300
-35,600
| -16% | -$125K |
|
2164
Conagra Brands
CAG
$9.18B
| $628K | ﹤0.01% |
+22,638
| New | +$628K |
|
2165
e.l.f. Beauty
ELF
$7.67B
| $628K | ﹤0.01% |
5,000
-73,408
| -94% | -$9.22M |
|
2166
Kite Realty
KRG
$4.95B
| $623K | ﹤0.01% |
24,672
-69,219
| -74% | -$1.75M |
|
2167
Invesco S&P MidCap 400 Pure Value ETF
RFV
$275M
| $623K | ﹤0.01% |
5,133
| – | – |
|
2168
KalVista Pharmaceuticals
KALV
$705M
| $621K | ﹤0.01% |
73,286
-16,643
| -19% | -$141K |
|
2169
Bridgewater Bancshares
BWB
$457M
| $619K | ﹤0.01% |
45,795
+13,963
| +44% | +$189K |
|
2170
Omega Flex
OFLX
$340M
| $619K | ﹤0.01% |
14,740
-300
| -2% | -$12.6K |
|
2171
Lyell Immunopharma
LYEL
$246M
| $618K | ﹤0.01% |
48,313
+24,682
| +104% | +$316K |
|
2172
Vanguard Consumer Staples ETF
VDC
$7.61B
| $616K | ﹤0.01% |
+2,913
| New | +$616K |
|
2173
Cadence Design Systems
CDNS
$93.6B
| $610K | ﹤0.01% |
2,031
-5,471
| -73% | -$1.64M |
|
2174
Southern Missouri Bancorp
SMBC
$628M
| $610K | ﹤0.01% |
10,635
-1,166
| -10% | -$66.9K |
|
2175
Euroseas
ESEA
$448M
| $609K | ﹤0.01% |
20,684
-26,581
| -56% | -$783K |
|